A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Myelin Oligodendrocyte Glycoprotein FACS Assay
MessageSendout, Mayo test code: MOGFS
Test Code
LAB5211541
Alias/See Also
MOG-IgG
MOG
Optic Neuritis Antibody
Transverse Myelitis Antibody
Vision Loss Antibody
ADEM antibody
NMO antibody
Fluorescence0Activated Cell Sorting
MOGFS
MOG
Optic Neuritis Antibody
Transverse Myelitis Antibody
Vision Loss Antibody
ADEM antibody
NMO antibody
Fluorescence0Activated Cell Sorting
MOGFS
CPT Codes
86363
Includes
When the results of this assay require further evaluation, the reflex titer test will be performed at an additional charge.
Preferred Specimen
2 mL serum from a red tube
Patient Preparation
For optimal antibody detection, specimen collection should occur prior to initiation of immunosuppressant medication.
Minimum Volume
1 mL
Other Acceptable Specimens
Serum gel tube
Instructions
Centrifuge and aliquot serum into a plastic vial.
Transport Container
Plastic vial
Transport Temperature
Refrigerated
Specimen Stability
Refrigerated (preferred): 28 days
Frozen: 28 days
Ambient: 72 hours
Frozen: 28 days
Ambient: 72 hours
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Gross hemolysis: Reject
Gross lipemia: Reject
Gross icterus: Reject
Gross lipemia: Reject
Gross icterus: Reject
Methodology
Flow Cytometry
FDA Status
Approved
Setup Schedule
Monday, Tuesday, Thursday
Report Available
5-8 days
Limitations
Myelin oligodendrocyte glycoprotein (MOG)-IgG, specifically MOG-IgG1, may drop below detectable levels in setting of therapies for acute attack (IV methylprednisolone or plasmapheresis) or attack prevention (immunosuppressants).
Reference Range
Included with report
Clinical Significance
Diagnosis of inflammatory demyelinating diseases (IDD) with similar phenotype to neuromyelitis optica (NMO) spectrum disorder (NMOSD), including optic neuritis (single or bilateral) and transverse myelitis
Diagnosis of autoimmune myelin oligodendrocyte glycoprotein (MOG)-opathy
Diagnosis of NMO
Distinguishing NMOSD, acute disseminated encephalomyelitis (ADEM), optic neuritis, and transverse myelitis from multiple sclerosis early in the course of disease
Diagnosis of ADEM
Prediction of a relapsing disease course
Diagnosis of autoimmune myelin oligodendrocyte glycoprotein (MOG)-opathy
Diagnosis of NMO
Distinguishing NMOSD, acute disseminated encephalomyelitis (ADEM), optic neuritis, and transverse myelitis from multiple sclerosis early in the course of disease
Diagnosis of ADEM
Prediction of a relapsing disease course
Performing Laboratory
Mayo Clinic Laboratories, Rochester, Minnesota
Additional Information
Myelin Oligodendrocyte Glycoprotein (MOG-IgG1) Fluorescence-Activated Cell Sorting (FACS) Assay, Serum